Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2015 08:30 ET | Source: Biocept, Inc.

Biocept to Present at the 27th Annual ROTH Conference

SAN DIEGO, March 3, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis in circulating tumor cell (CTC) and circulating...
March 02, 2015 08:30 ET | Source: Biocept, Inc.

Dr. David Rimm Joins Biocept, Inc. as a Scientific Advisor

SAN DIEGO, March 2, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA and circulating...
February 25, 2015 16:15 ET | Source: Biocept, Inc.

Biocept, Inc. Schedules Webcast and Conference Call for Fourth Quarter 2014 Financial Results

SAN DIEGO, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA (ctDNA) and circulating...
February 23, 2015 08:30 ET | Source: Biocept, Inc.

Study Highlights Value of Biocept's Blood-Based Diagnostic for Determining Hormonal Status in Patients With Metastatic Breast Cancer

SAN DIEGO, Feb. 23, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA (ctDNA) and...
February 09, 2015 18:21 ET | Source: Biocept, Inc.

Biocept, Inc. Prices $10,000,000 Public Offering

SAN DIEGO, Feb. 9, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA and circulating tumor...
January 20, 2015 08:30 ET | Source: Biocept, Inc.

Biocept Introduces New Test for Patients With Non-Small Cell Lung Cancer

SAN DIEGO, Jan. 20, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA (ctDNA) and Circulating...
January 12, 2015 08:30 ET | Source: Biocept, Inc.

Biocept Launches Selector(TM), a Blood Based Test for EGFR Mutations for Non-Small Cell Lung Cancer Patients

SAN DIEGO, Jan. 12, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA (ctDNA) and Circulating...
January 08, 2015 08:30 ET | Source: Biocept, Inc.

Biocept and Insight Genetics Collaborate to Advance Non-Small Cell Lung Cancer Diagnosis and Treatment

SAN DIEGO and NASHVILLE, Tenn., Jan. 8, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor...
January 07, 2015 09:00 ET | Source: Biocept, Inc.

Biocept to Present at the 8th Annual OneMedForum

SAN DIEGO, Jan. 7, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis in circulating tumor cell (CTC) and circulating...
January 07, 2015 08:30 ET | Source: Biocept, Inc.

Biocept's Proprietary Oncology Diagnostics to be Offered on America's Choice Provider Network

SAN DIEGO, Jan. 7, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor cells (CTCs) and circulating...